Literature DB >> 20809449

Long-term angiographic and histological results of a new hydrogel-containing filling coil in experimental rabbit aneurysms.

M Killer1, D Kallmes, R Jones, Y Ding, M Vestal, T Hauser, R Virmani, G Cruise.   

Abstract

BACKGROUND: The aim of this study was to compare the performance of a new filling coil, the HydroFill device, to historical results of HydroSoft and bare platinum coil devices in experimental rabbit aneurysms.
METHODS: Experimental aneurysms were constructed in rabbits and embolized with HydroFill (n=32), HydroSoft (n=48), or bare platinum coil (n=47) devices. Angiographic occlusion was evaluated post-treatment and at 1 month (n=55), 3 month (n=20), 6 month (n=35), and 12 month (n=12) follow-ups according to the Raymond scale. The aneurysms were analyzed histologically for neointima formation, thrombus organization, and inflammation. Continuous and discrete results were compared using ANOVA/t-test and chi (2) tests, respectively.
RESULTS: Volumetric occlusion of the aneurysm sac was increased in the HydroFill group compared to the HydroSoft and platinum coil groups. Protrusions into the parent artery were common in all treatment groups due to the treatment of wide-necked aneurysms without the use of balloons or stents. Although angiographic occlusion post-treatment scores were reduced in the HydroFill group compared to the HydroSoft and platinum coil groups, stable/progressive occlusion was increased in the HydroFill group compared to the platinum coil group. Histologically, neointima formation and thrombus organization scores were increased in the HydroFill and HydroSoft groups compared to the platinum coil group at 3 months. Although there were some differences in the scoring, inflammation was generally minimal to mild in all three groups.
CONCLUSION: The HydroFill device, with its high levels of volumetric filling, increased stable/progressive occlusion at follow-up, increased neointima formation, and increased thrombus organization, shows promise for clinical use. Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809449     DOI: 10.1055/s-0030-1252059

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  6 in total

1.  GREAT-a randomized aneurysm trial. Design of a randomized controlled multicenter study comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment.

Authors:  Christian Taschner; René Chapot; Vincent Costalat; Patrick Courthéoux; Xavier Barreau; Jerome Berge; Laurent Pierot; Kryzsztof Kadziolka; Betty Jean; Raphael Blanc; Alessandra Biondi; Hervé Brunel; Sophie Gallas; Ansgar Berlis; Denis Herbreteau; Joachim Berkefeld; Christoph Groden; Horst Urbach; Samer El Shikh; Erika Graf; Alain Bonafé
Journal:  Neuroradiology       Date:  2015-02-28       Impact factor: 2.804

2.  New generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): a study protocol for a multicenter randomized controlled trial.

Authors:  Karl R Abi-Aad; Rami James N Aoun; Rudy J Rahme; Jennifer D Ward; Jason Kniss; Mary Jeanne Kwasny; Mithun G Sattur; Matthew E Welz; Bernard R Bendok
Journal:  Neuroradiology       Date:  2018-08-17       Impact factor: 2.804

3.  GREAT-a randomized controlled trial comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment: procedural safety and core-lab-assessedangiographic results.

Authors:  Christian A Taschner; René Chapot; Vincent Costalat; Paolo Machi; Patrick Courthéoux; Xavier Barreau; Jérôme Berge; Laurent Pierot; Kryzsztof Kadziolka; Betty Jean; Raphaël Blanc; Alessandra Biondi; Hervé Brunel; Sophie Gallas; Ansgar Berlis; Denis Herbreteau; Joachim Berkefeld; Horst Urbach; Samer El Shikh; Jens Fiehler; Hubert Desal; Erika Graf; Alain Bonafé
Journal:  Neuroradiology       Date:  2016-04-30       Impact factor: 2.804

4.  HydroCoils Are Associated with Lower Angiographic Recurrence Rates Than Are Bare Platinum Coils in Treatment of "Difficult-to-Treat" Aneurysms: A Post Hoc Subgroup Analysis of the HELPS Trial.

Authors:  W Brinjikji; P M White; H Nahser; J Wardlaw; R Sellar; A Gholkar; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

5.  The next generation HydroCoil: initial clinical experience with the HydroFill embolic coil.

Authors:  John W D Speirs; Thomas H Burke; Stefanie Y Lee; Brigitte D Ala
Journal:  J Neurointerv Surg       Date:  2013-04-23       Impact factor: 5.836

6.  Histological and Transmission Electron Microscopy Results after Embolization with HydroSoft/HydroFrame Coils in Experimental Swine Aneurysm.

Authors:  Seisuke Iseki; Yumiko Mitome-Mishima; Ikuko Ogino; Yasuo Suga; Kenji Yatomi; Senshu Nonaka; Nobukazu Miyamoto; Akihide Kondo; Munetaka Yamamoto; Hajime Arai; Hidenori Oishi
Journal:  Biomed Res Int       Date:  2019-12-05       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.